Drug Trial Radar · NCT03636204
A First in Human Study in Healthy Volunteers and in Participants With Frontotemporal Dementia With Granulin (GRN) Mutation
Last checked: Nov 19, 2026Latest source record: Jul 27, 2020 (this record)Source: ClinicalTrials.govMethods & limitations
Status
Completed
Enrollment
64
Actual
Start
Sep 14, 2018
Primary completion
Dec 31, 2019
Study completion Dec 31, 2019
Sponsor
- Lead sponsor
- Alector Inc.Industry
- Sponsor type
- Industry
- First posted
- Aug 17, 2018
Design
- Study type
- Interventional
- Phase
- Phase 1
- Allocation
- Randomized
- Model
- Parallel
- Masking
- Quadruple (participant, care provider, investigator, outcomes assessor)
- Primary purpose
- Treatment
- FDA-regulated drug
- Yes
- Who can join
- All sexes, from 18 years, up to 80 years
- Healthy volunteers
- Yes
Summary
As written by the sponsor on the registry.
A first in human phase 1 study in healthy volunteers and participants with Granulin (GRN) mutation causative of frontotemporal dementia (FTD) to assess AL001 safety, tolerability, pharmacokinetics, and pharmacodynamics
Conditions
- Healthy
- Frontotemporal Dementia
Interventions
AL001Biological
Active dose of AL001
PlaceboOther
Saline solution administered as a single infusion as palcebo.
Primary outcomes
What the sponsor says the trial is designed to measure.
- Evaluation of safety and tolerability of AL001 measured by number of subjects with adverse events and Dose Limiting Adverse Event (DLAEs)Time frame: 85 days
Locations
8 sites in 3 countries. Site status is shown where the registry gives one.
University of Alabama
Birmingham, Alabama
UCSF
San Francisco, California
Study site
Orlando, Florida
Mayo Clinic
Rochester, Minnesota
University of Pennsylvania
Philadelphia, Pennsylvania
Sunnybrook Health Sciences Centre
Toronto, Canada
Lawson Health Research Institute, St. Joseph's
London, Ontario, Canada
University College London
London, United Kingdom
Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.
For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.